Profile
Albertien Greijdanus was the founder of Alleviant Medical, Inc. and held the title of Director & Chief Compliance Officer since its founding in 2017.
Ms. Greijdanus is currently a Senior Investment Manager at Brabantse Ontwikkelings Maatschappij Holding BV, starting in 2024.
Education includes an undergraduate degree from Delft University of Technology conferred in 2008 and a graduate degree conferred in 2011.
Albertien Greijdanus active positions
| Companies | Position | Start |
|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 2023-12-31 |
Former positions of Albertien Greijdanus
| Companies | Position | End |
|---|---|---|
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Founder | - |
Training of Albertien Greijdanus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Commercial Services |
- Stock Market
- Insiders
- Albertien Greijdanus
















